APA (7th ed.) Citation

SA, A., A, S., HM, G., RR, G., D, M., A, S., . . . EJ, W. (2022). Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19. Frontiers in immunology, 13, 834988. https://doi.org/10.3389/fimmu.2022.834988

Chicago Style (17th ed.) Citation

SA, Apostolidis, et al. "Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19." Frontiers in Immunology 13 (2022): 834988. https://doi.org/10.3389/fimmu.2022.834988.

MLA (9th ed.) Citation

SA, Apostolidis, et al. "Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19." Frontiers in Immunology, vol. 13, 2022, p. 834988, https://doi.org/10.3389/fimmu.2022.834988.